News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InVivo Therapeutics Corporation (NVIV) Names Thomas R. Ulich, MD As Its New Chief Scientific Officer


2/24/2014 6:45:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

InVivo Therapeutics Holdings Corp. (NVIV) today announced appointment of Thomas R. Ulich, MD as Chief Scientific Officer, effective February 24, 2014.

Dr. Ulich previously served as Executive Vice-President of Research and Development of ConjuChem Biotechnologies from 2006 - 2010. Prior to that, he served as Senior Vice-President of Research and Development for Alnylam Pharmaceuticals from 2003-2004.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES